Next Article in Journal
Distinct Properties of Human M-CSF and GM-CSF Monocyte-Derived Macrophages to Simulate Pathological Lung Conditions In Vitro: Application to Systemic and Inflammatory Disorders with Pulmonary Involvement
Next Article in Special Issue
Growth Hormone Receptor Mutations Related to Individual Dwarfism
Previous Article in Journal
Health Risks of Hypovitaminosis D: A Review of New Molecular Insights
Previous Article in Special Issue
Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?
Open AccessReview

Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks

1
Department of Endocrinology, Hospital Ramón y Cajal, 28034 Madrid, Spain
2
Department of Medicine, University of Alcalá de Henares, 28034 Madrid, Spain
3
Faculty of Health Sciences, University of A Coruña, 15006 A Coruña, Spain
4
Instituto de Investigación Biomedica (INIBIC), University Hospital A Coruña, 15006 A Coruña, Spain
5
Department of Endocrinology, University Hospital A Coruña, Xubias de Arriba 84, 15006 A Coruña, Spain
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(3), 893; https://doi.org/10.3390/ijms19030893
Received: 11 February 2018 / Revised: 7 March 2018 / Accepted: 14 March 2018 / Published: 17 March 2018
(This article belongs to the Special Issue Growth Hormone: Therapeutic Possibilities)
Pharmacological treatment of growth hormone deficiency (GHD) in adults began in clinical practice more than 20 years ago. Since then, a great volume of experience has been accumulated on its effects on the symptoms and biochemical alterations that characterize this hormonal deficiency. The effects on body composition, muscle mass and strength, exercise capacity, glucose and lipid profile, bone metabolism, and quality of life have been fully demonstrated. The advance of knowledge has also taken place in the biological and molecular aspects of the action of this hormone in patients who have completed longitudinal growth. In recent years, several epidemiological studies have reported interesting information about the long-term effects of GH replacement therapy in regard to the possible induction of neoplasms and the potential development of diabetes. In addition, GH hormone receptor polymorphism could potentially influence GH therapy. Long-acting GH are under development to create a more convenient GH dosing profile, while retaining the excellent safety, efficacy, and tolerability of daily GH. In this article we compile the most recent data of GH replacement therapy in adults, as well as the molecular aspects that may condition a different sensitivity to this treatment. View Full-Text
Keywords: growth hormone; growth hormone deficiency; hypopituitarism; treatment growth hormone; growth hormone deficiency; hypopituitarism; treatment
MDPI and ACS Style

Díez, J.J.; Sangiao-Alvarellos, S.; Cordido, F. Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks. Int. J. Mol. Sci. 2018, 19, 893.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop